Your Good Partner in Biology Research

  1. 首頁
  2. 試劑盒
  3. 酶聯(lián)免疫試劑盒
  4. Human Glutathione S-transferase omega-1(GSTO1) ELISA kit

Human Glutathione S-transferase omega-1(GSTO1) ELISA kit

  • 中文名稱：
    人谷胱甘肽S-轉(zhuǎn)移酶ω-1(GSTO1)酶聯(lián)免疫試劑盒
  • 貨號：
    CSB-EL009986HU
  • 規(guī)格：
    96T/48T
  • 價格：
    ￥3600/￥2500
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：

    This Human GSTO1 ELISA Kit was designed for the quantitative measurement of Human GSTO1 protein in serum, plasma, tissue homogenates, cell lysates. It is a Sandwich ELISA kit, its detection range is 31.2 pg/mL-2000 pg/mL and the sensitivity is 7.8 pg/mL.

  • 別名：
    AA407097 ELISA Kit; AI194287 ELISA Kit; AU018802 ELISA Kit; DKFZp686H13163 ELISA Kit; EC 2.5.1.18 ELISA Kit; Glutathione S transferase omega 1 ELISA Kit; Glutathione S-transferase omega 1-1 ELISA Kit; Glutathione S-transferase omega ELISA Kit; Glutathione S-transferase omega-1 ELISA Kit; Glutathione transferase omega 1 ELISA Kit; Glutathione-dependent dehydroascorbate reductase ELISA Kit; Glutathione-S-transferase like ELISA Kit; Glutathione-S-transferase omega 1 ELISA Kit; GSTO 1-1 ELISA Kit; GSTO-1 ELISA Kit; GSTO1 1 ELISA Kit; Gsto1 ELISA Kit; GSTO1_HUMAN ELISA Kit; GSTTLp28 ELISA Kit; GSTX ELISA Kit; Gtsttl ELISA Kit; MGC94845 ELISA Kit; MMA(V) reductase ELISA Kit; Monomethylarsonic acid reductase ELISA Kit; OTTHUMP00000020429 ELISA Kit; p28 ELISA Kit; S-(Phenacyl)glutathione reductase ELISA Kit; SPG-R ELISA Kit
  • 縮寫：
    GSTO1
  • Uniprot No.：
  • 種屬：
    Homo sapiens (Human)
  • 樣本類型：
    serum, plasma, tissue homogenates, cell lysates
  • 檢測范圍：
    31.2 pg/mL-2000 pg/mL
  • 靈敏度：
    7.8 pg/mL
  • 反應(yīng)時間：
    1-5h
  • 樣本體積：
    50-100ul
  • 檢測波長：
    450 nm
  • 研究領(lǐng)域：
    Tags & Cell Markers
  • 測定原理：
    quantitative
  • 測定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%        
    Three samples of known concentration were tested twenty times on one plate to assess.    
    Inter-assay Precision (Precision between assays): CV%<10%        
    Three samples of known concentration were tested in twenty assays to assess.      
                   
  • 線性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human GSTO1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.  
    　 Sample Serum(n=4)    
    1:1 Average % 87    
    Range % 83-94    
    1:2 Average % 98    
    Range % 94-102    
    1:4 Average % 93    
    Range % 86-97    
    1:8 Average % 104    
    Range % 97-108    
  • 回收率：
    The recovery of human GSTO1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.  
     
    Sample Type Average % Recovery Range    
    Serum (n=5) 93 87-96    
    EDTA plasma (n=4) 89 85-94    
                   
                   
  • 標(biāo)準(zhǔn)曲線：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.  
     
    pg/ml OD1 OD2 Average Corrected    
    2000 2.304 2.281 2.293 2.117    
    1000 1.453 1.373 1.413 1.237    
    500 0.888 0.862 0.875 0.699    
    250 0.534 0.520 0.527 0.351    
    125 0.395 0.383 0.389 0.213    
    62.5 0.292 0.285 0.289 0.113    
    31.2 0.246 0.238 0.242 0.066    
    0 0.178 0.173 0.176 　    
  • 數(shù)據(jù)處理：
  • 貨期：
    3-5 working days

產(chǎn)品評價

靶點(diǎn)詳情

  • 功能：
    Exhibits glutathione-dependent thiol transferase and dehydroascorbate reductase activities. Has S-(phenacyl)glutathione reductase activity. Has also glutathione S-transferase activity. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA) and dimethylarsonic acid.
  • 基因功能參考文獻(xiàn)：
    1. the effect of specific GSTO1 and GSTO2 gene variants, independently and in interaction with established risk factors (smoking, obesity and hypertension) on the risk for the most aggressive renal cell carcinoma (RCC) subtype, the clear cell RCC, is reported. PMID: 30224590
    2. Results showed that the variants rs11191979, rs2164624 and rs4925 of GSTO1 provide the susceptibility toward developing arsenic-induced skin lesions in individuals exposed to high-dose inorganic arsenic in northwest China. PMID: 29323258
    3. Significant correlation between severities of skin manifestations with GSTO1 polymorphism status in arsenic-exposed population of India. PMID: 28436716
    4. GSTO1*C is linked to the pre-stage of Alzheimer's disease; rs4925 could be a genetic marker for cognitive impairment PMID: 27259244
    5. This study demonstrated that Distribution of the GSTO1 alleles and genotypes was nearly equal between the control group and SCA2 patients. GSTO1 genotypes were not associated to clinical markers in SCA2 patients. PMID: 28017238
    6. GSTO1 genetic polymorphisms are associated with the progression of HBV infection. PMID: 27221910
    7. GSTP1 and GSTO1 polymorphisms are associated with epirubicin treatment outcomes as well as with epirubicin-related toxicity. PMID: 26354850
    8. No significant association has been found between childhood Pre-B acute lymphoblastic leukemia and GSTO1 A140D and GSTO2 N142D polymorphisms. PMID: 25726706
    9. The present study provided epidemiological evidence for a significantly increased risk of UCB in ever smokers with the Ala/Ala genotype of the GSTO1 gene and the Arg/Arg genotype of the SULT1A1 gene. PMID: 25103078
    10. Our results indicate that GSTO1*C/GSTO2*G haplotype is associated with increased risk of TCC. The modifying effect of GSTO2*G/G genotype on individual susceptibility to TCC is more pronounced, when associated with smoking. PMID: 25716313
    11. This meta-analysis demonstrates that GSTO2 polymorphism may significantly increase cancer risk in Caucasian population and is associated with elevated risk of breast cancer; while GSTO1 polymorphism is not associated with cancer risk. PMID: 25300926
    12. Our study is the first to show that the frequency of GSTO1 A140D gene polymorphism in the Turkish population is similar to other Caucasian populations and that this polymorphism is not associated with susceptibility to NSCLC. PMID: 23819933
    13. Overexpression of GSTO1 is associated with esophageal squamous cell carcinoma. PMID: 25085586
    14. GSTT1 active genotype and GSTO1 Asp140Asp and GSTO2 Asp142Asp genotypes may have a prognostic/pharmacogenomic role in patients with muscle invasive bladder cancer. PMID: 24040330
    15. Genetic variants in GSTO1 are associated with increased risk for recurrent miscarriage. PMID: 24417908
    16. The common A140D genetic polymorphism in GSTO1 was found to have significant effects on the kinetics of both the deglutathionylation and glutathionylation reactions. PMID: 23888047
    17. The frequencies of GSTO1 and GSTO2 genotypes were not significantly different between head and neck squamous cell carcinoma cases and controls. PMID: 23086268
    18. Single nucleotide polymorphisms (SNPs) in arsenic methyltransferase and methylene-tetrahydrofolate reductase is associated with bladder cancer in those exposed to low concentrations of inorganic arsenic. SNPs in glutathione S-transferase omega-1 are not. PMID: 22747749
    19. GSTO-1 plays a key role in hormesis induced by low dose trichloroethylene. PMID: 21351650
    20. Our studies confirm the lack of association between GSTO1 variants and essential hypertension risk, also for two uncommon genetic variants with large functional effects in italian patients. PMID: 22283150
    21. Results suggest a role of GSTO1-1 in the inflammatory response and the apoptotic process and indicate that A140D and E208K polymorphisms could increase risk of developing inflammatory and apoptosis-related diseases in As-exposed populations. PMID: 22293942
    22. low monomethylarsonic acid is associated with increased risk for MetS among As-exposed subjects and the genetic polymorphism of GSTO1 PMID: 22440634
    23. The minor allele of GSTO1 rs4925 associates with decreased risk in familial Parkinson disease. The minor alleles of GSTO1 rs4925 and GSTO2 rs156697 SNPs associate with lower brain levels of GSTO2, but not GSTO1. PMID: 22494505
    24. the crystal structure of a human GSTO1-1 has been determined at 1.7 A resolution in complex with the reaction product ascorbic acid PMID: 22522127
    25. Genetic polymorphisms GSTO and As3MT modify arsenic metabolism as evidenced by altered urinary arsenic excretion PMID: 22339537
    26. we hypothesized that GSTO1*E155del is an uncommon genetic variant associated with Alzheimer's Disease risk. PMID: 22100662
    27. These findings supported a role of the GSTO1 rs4925 single nucleotide polymorphism in the risk of sporadic Alzheimer disease in southern Italy. PMID: 20818931
    28. Novel folding and stability defects cause a deficiency of human glutathione transferase omega 1. PMID: 21106529
    29. Has a role in the risk Urothelial carcinogenesis PMID: 21094982
    30. the distribution of the GSTO2 gene differed significantly between asthmatics and controls PMID: 20374258
    31. This study provides the allele frequencies of GSTO polymorphism in a sample consisting of 116 apparently healthy individuals of both sexes from Rome (Central Italy). PMID: 20113212
    32. it is unlikely that glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 participate in breast cancer susceptibility. PMID: 19859803
    33. GSTO1-1 overexpression appears to be associated with activation of survival pathways (Akt and ERK1/2) and inhibition of apoptotic pathways (JNK1), as well as protection against cisplatin-induced apoptosis. PMID: 20106899
    34. The GSTO1-140Asp/GSTO2-142Asp haplotype was associated with increased risk of COPD. PMID: 19513904
    35. polymorphisms in GSTO1 or GSTO2 do not appear to contribute to the large individual variability in arsenic metabolism or susceptibility to arsenicosis. PMID: 19635583
    36. Data describe the functional characterization of two variants of human glutathione-s-transferase omega. PMID: 12565892
    37. Arsenic metabolism associated hGSTO1-1 in the European ancestry group was more polymorphic than the Indigenous American Ancestry groups. Mexican Hispanics, could vary in the extent of polymorphism in these genes based upon the admixture. PMID: 12928150
    38. a significant association was found for GSTO1 (P=0.007) and a second transcribed member of the GST omega class, GSTO2 (P=0.005), located next to GSTO1. PMID: 14570706
    39. Our results do not confirm an association between PD and frequency of hGSTO2*N142D. PMID: 15159516
    40. 2 missense polymorphisms in exon 4 (Ala140Asp & Glu155DeltaGlu) were detected. Asp allele genotype affected CSF cholesterol, serum homocysteine. risk of vascular dementia, stroke, and early-onset Alzheimer's disease. PMID: 15623683
    41. no association either with age-at-onset in AD cases or with disease risk in the case-control cohort but haplotype analysis revealed a modest association of one haplotype with AD risk (p = 0.04 PMID: 15917099
    42. For E155del, the mutation frequency in Ovambo and Japanese subjects was 0.000 and 0.017, respectively, similar to those for other populations. As for E208K polymorphism, no mutation allele was found in Ovambo or Japanese subjects. PMID: 17484623
    43. Glutathione S-transferase omega is abundant in alveolar macrophages and airway secretions, with the levels decreased in patients with chronic obstructive pulmonary disease. PMID: 17617905
    44. The GSTO1 Asp/Asp genotype presumably modulates the severity and expansion of atherosclerosis in the circle of Willis PMID: 17717316
    45. The prevalence of the GSTO1 140A varied significantly among different regional populations in China, which showed that geography played a more important role in the population differentiation for this allele than the ethnicity/race PMID: 18400112
    46. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. PMID: 18414193
    47. These results suggest a possible effect of the GSTO1 and 2 locus on age of onset of FALS. PMID: 18427999
    48. These data establish the fact that the polymorphic deletion of Glu155 can cause GSTO1-1 deficiency in vivo. PMID: 18571971
    49. GSTO2*N142D genotype is significantly associated with high rish of childhood acute lymhpoblastic leukemia. PMID: 18941778
    50. Report GSTO1 gene polymorphisms in worldwide populations. PMID: 18986335

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Cytoplasm, cytosol.
  • 蛋白家族：
    GST superfamily, Omega family
  • 組織特異性：
    Ubiquitous. Highest expression in liver, pancreas, skeletal muscle, spleen, thymus, colon, blood leukocyte and heart. Lowest expression in brain, placenta and lung.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 13312

    OMIM: 605482

    KEGG: hsa:9446

    STRING: 9606.ENSP00000358727

    UniGene: Hs.190028